A phase I study of the first-in-class antimitochondrial metabolism agent, CPI-613, in patients with advanced hematologic malignancies.

A phase I study of the first-in-class antimitochondrial metabolism agent, CPI-613, in patients with advanced hematologic malignancies.

Item
http://www.wikidata.org/entity/Q34353111
Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial.Translational assessment of mitochondrial dysfunction of pancreatic cancer from in vitro gene microarray and animal efficacy studies, to early clinical studies, via the novel tumor-specific anti-mitochondrial agent, CPI-613.A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung CarcinomaThe emerging role and targetability of the TCA cycle in cancer metabolism.Therapeutic Options for Aggressive T-Cell Lymphomas.Temperature induces significant changes in both glycolytic reserve and mitochondrial spare respiratory capacity in colorectal cancer cell lines.Recent advances in understanding and managing T-cell lymphoma.Targeting Metabolism for Cancer Therapy.Pharmacologic Reprogramming Designed to Induce a Warburg Effect in Porcine Fetal Fibroblasts Alters Gene Expression and Quantities of Metabolites from Conditioned Media Without Increased Cell Proliferation.A phase I study of CPI-613 in combination with high dose cytarabine and mitoxantrone for relapsed or refractory acute myeloid leukemia.Therapeutic potential of CPI-613 for targeting tumorous mitochondrial energy metabolism and inhibiting autophagy in clear cell sarcoma.
P2860

A phase I study of the first-in-class antimitochondrial metabolism agent, CPI-613, in patients with advanced hematologic malignancies.

Item
http://www.wikidata.org/entity/Q34353111
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A phase I study of the first-i ...... nced hematologic malignancies.
@ast
A phase I study of the first-i ...... nced hematologic malignancies.
@en
A phase I study of the first-i ...... nced hematologic malignancies.
@nl
type
label
A phase I study of the first-i ...... nced hematologic malignancies.
@ast
A phase I study of the first-i ...... nced hematologic malignancies.
@en
A phase I study of the first-i ...... nced hematologic malignancies.
@nl
prefLabel
A phase I study of the first-i ...... nced hematologic malignancies.
@ast
A phase I study of the first-i ...... nced hematologic malignancies.
@en
A phase I study of the first-i ...... nced hematologic malignancies.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
A phase I study of the first-i ...... anced hematologic malignancies
@en
P2093
P2860
P304
P31
P356
10.1158/1078-0432.CCR-14-1019
P407
P433
P478
P50
P577
P698
P932